Article
- July 2024 Vol 30.7Alternative Approaches for the Management of Urinary Tract Infection with Crano-cure: A Randomized Clinical TrialAuthors: Khalil Ahmed MS, Mukhtiar Ahmed MPhil, Hafiz Muhammad Asif BEMS, PhD, Faheem Hadi PhD, Asif Iqbal PhD, Laila Sumreen MPhil, Mujadid Ur Rehman PhDAbstract:Keywords: alternative approaches, urinary tract infections, herbal formulation, toxicity, randomized clinical trials
Background • Urinary tract infection (UTI) is a renal infection that affects the urinary tract and is global problem related to health and many people are affected each year at some points of their lives. Modern studies about urinary tract infections show that almost one third of the world’s population has been suffering from this ailment. Different antibacterial medicines have been reported to have resistance against pathogens. In order to overcome the problem, exploration for new and dynamic antibacterial agents from natural sources is the emerging trend.
Primary Study Objective • The primary objective was to evaluate the efficacy and safety of the polyherbal test drug formulation, “Crano-cure”, as treatment for UTIs.
Methods/Design • In the current study, clinical trials were designed to evaluate the effects of the polyherbal formulation “Crano-cure” compared to the standard drug Ciprofloxacin in randomized, controlled multicenter trial of 205 patients, analyzing clinical outcomes and safety profiles.
Setting and Participants • Conducted across multiple centers, including Shifa-ul-Mulk Memorial Hospital at Hamdard University Karachi and three other clinics, the study involved 205 patients aged 15-60, irrespective of their socioeconomic status.
Intervention • Patients were classified into two groups i.e. control group (ciprofloxacin) and the test group (crane-cure). Polyherbal formulation of 500 mg Crano-cure capsules two times in a day were administered to the test group for 28 days. The control group was administered a control ciprofloxacin tablet 500 mg two times in a day for 28 days.
Primary Outcome Measures • The drug was found safe for further clinical study after observing changes or improvements in UTI symptoms, urine culture and blood complete tests. The clinical trial was dully registered on the US National Library of Medicine, ClinicalTrials.gov Identifier: NCT04575493. The trial was accompanied in the instructions of EC (Ethical Committee). The study plan and procedures were displayed to the BASR (Board of Advance Studies and Research) and board members of the Ethical Committee (EC), which was ERB-2021-9-1.
Results • Clinical study results revealed the effectiveness of Crano-cure in the management of UTIs symptoms and hematological and biochemical parameters including blood complete test, liver function tests, renal function tests and lipid profile. Moreover, the test drug Crano-cure revealed a significance level (P = .05) in compliance and cost-effectiveness compared to control ciprofloxacin.
Conclusion • In conclusion, Crano-cure is a safe and cost-effective alternate to Ciprofloxacin for treatment of UTIs.
Open Access: No
Login to view article full text | Buy this article for $35.00
